ArticleJournal of experimental & clinical cancer research : CR2017

Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).

Guanggai Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.